SAGE Open Med Case Rep 2017 14;5:2050313X17741010. Epub 2017 Nov 14.
Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA.
Tenofovir is a nucleotide analog reverse transcriptase inhibitor approved for the treatment of HIV and hepatitis B infections. It is widely prescribed and an integral part of the recommended regimens for the treatment of HIV infection in antiretroviral-naive patients. Tenofovir is implicated in renal proximal tubular dysfunction, which can be associated with Fanconi syndrome and hypokalemia. Read More